CSF biomarkers in frontotemporal lobar degeneration with known pathology

OBJECTIVE: To evaluate the diagnostic value of CSF biomarkers in patients with known pathology due to frontotemporal lobar degeneration (FTLD). BACKGROUND: It is important to distinguish FTLD from other neurodegenerative diseases like Alzheimer disease (AD), but this may be difficult clinically beca...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bian, H., Van Swieten, J.C., Leight, S., Massimo, L., Wood, E., Forman, M., Moore, P., de Koning, I., Clark, C.M., Rosso, S., Trojanowski, J., Lee, V.M.-Y., Grossman, M.
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2707002/
https://ncbi.nlm.nih.gov/pubmed/18458217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/01.wnl.0000311445.21321.fc
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars